(Q35208400)

7 August 2017

title

Long-term safety of tacrolimus ointment in children treated for atopic dermatitis (English)

1 reference

7 August 2017

0 references

1 reference

Tsippora Shainhouse

1

1 reference

7 August 2017

Lawrence F Eichenfield

series ordinal

2

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Expert Opinion on Drug Safety

7 August 2017

published in

1 reference

7 August 2017

volume

2

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

457-465

1 reference

Allergy: etiology and epidemiology

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

The prevalence of atopic dermatitis in Oregon schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Role of social factors in atopic dermatitis: the US perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Cost of atopic dermatitis and eczema in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Atopic eczema: its impact on the family and financial cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Topical immunomodulators for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Pathophysiologic mechanisms in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Macrolactam immunomodulators for topical treatment of inflammatory skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Safety of the new macrolide immunomodulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

National Transplantation Pregnancy Registry: analysis of pregnancy outcomes in female liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

New aspects of the mechanism of corticosteroid–induced dermal atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Tacrolimus ointment improves psoriasis in a microplaque assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Inhibition of contact allergy reactions by topical FK506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Erosive mucosal lichen planus: response to topical treatment with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Pimecrolimus cream 1%: a new development in nonsteroid topical treatment of inflammatory skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Topical tacrolimus and pimecrolimus: future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

Hanifin's and Rajka's minor criteria for atopic dermatitis: Which do 2-year-olds exhibit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2.5.457

21 January 2018

Identifiers

DOI

10.1517/14740338.2.5.457

1 reference

7 August 2017

1 reference